Standout Papers

ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor 2008 2026 2014 2020 1.5k
  1. ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor (2008)
    Christin Tse, Alexander R. Shoemaker et al. Cancer Research

Immediate Impact

7 by Nobel laureates 39 from Science/Nature 107 standout
Sub-graph 1 of 20

Citing Papers

Alveolar fibroblast lineage orchestrates lung inflammation and fibrosis
2024 StandoutNature
CAR immune cells: design principles, resistance and the next generation
2023 StandoutNature
2 intermediate papers

Works of Michael J. Mitten being referenced

ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
2008 Standout

Author Peers

Author Last Decade Papers Cites
Michael J. Mitten 1858 818 265 355 27 2.7k
Stephen K. Tahir 2352 962 164 334 34 3.2k
Christin Tse 3425 869 172 372 24 4.2k
Mark G. Anderson 2009 971 304 212 47 3.3k
Sha Jin 1607 607 125 289 28 2.1k
Jean‐Baptiste Telliez 1186 785 227 271 36 2.8k
Lorenzo M. Leoni 1767 793 280 344 56 3.6k
Todd Busman 1437 646 266 449 42 2.6k
Amanda L. Christie 1563 990 128 613 34 2.4k
Antonia T. Destree 2410 837 253 465 28 3.8k
Anna Scuto 1385 662 80 299 30 2.2k

All Works

Loading papers...

Rankless by CCL
2026